What Happened?
Norwood, MA-based Corbus-Pharmaceuticals Appointed Yuval Cohen as Chief Executive Officer
About the Company
Corbus Pharmaceuticals Holdings, Inc.is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.
About the Person
Yuval Cohen is Chief Executive Officer at Corbus Pharmaceuticals. Previously, Yuval held various senior HR leadership roles in the industry.
Info Source
News
Short Profile